The Journal of Experimental Medicine
Torrey Pines Biolabs
  Home | Help | Feedback | Subscriptions | Archive | Search | Table of Contents

Published online
doi:10.1084/jem.20082767
The Journal of Experimental Medicine, Vol. 206, No. 6, 1291-1301
The Rockefeller University Press, 0022-1007 $30.00
© Minegishi et al.
This Article
Right arrow Full Text
Right arrow Full Text (PDF, 3335K)
Right arrow PDF+supp data (7285K)
Right arrow PPT slides of all figures
Right arrow Supplemental Material Index
Right arrow Alert me when this article is cited
Right arrow Citation Map
Services
Right arrow Email this article
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new content in the JEM
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via CrossRef
Google Scholar
Right arrow Articles by Minegishi, Y.
Right arrow Articles by Karasuyama, H.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Minegishi, Y.
Right arrow Articles by Karasuyama, H.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Facebook   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

ARTICLE

Molecular explanation for the contradiction between systemic Th17 defect and localized bacterial infection in hyper-IgE syndrome

Yoshiyuki Minegishi1, Masako Saito1, Masayuki Nagasawa2, Hidetoshi Takada3, Toshiro Hara3, Shigeru Tsuchiya4, Kazunaga Agematsu5, Masafumi Yamada6, Nobuaki Kawamura6, Tadashi Ariga6, Ikuya Tsuge7, and Hajime Karasuyama1

1 Department of Immune Regulation and 2 Department of Pediatrics and Developmental Biology, Graduate School, Tokyo Medical and Dental University, Tokyo 113-8519, Japan
3 Department of Pediatrics, Graduate School of Medical Sciences, Kyushu University, Fukuoka 812-0054, Japan
4 Department of Pediatrics, Tohoku University, Sendai 980-0872, Japan
5 Department of Pediatrics, Shinshu University, Matsumoto 390-8621, Japan
6 Department of Pediatrics, Hokkaido University Graduate School of Medicine, Sapporo 060-8638, Japan
7 Department of Pediatrics, Fujita Health University, Nagoya 470-1192, Japan

CORRESPONDENCE Yoshiyuki Minegishi: yminegishi.mbch{at}tmd.ac.jp

Hyper-IgE syndrome (HIES) is a primary immunodeficiency characterized by atopic manifestations and susceptibility to infections with extracellular pathogens, typically Staphylococcus aureus, which preferentially affect the skin and lung. Previous studies reported the defective differentiation of T helper 17 (Th17) cells in HIES patients caused by hypomorphic STAT3 mutations. However, the apparent contradiction between the systemic Th17 deficiency and the skin/lung-restricted susceptibility to staphylococcal infections remains puzzling. We present a possible molecular explanation for this enigmatic contradiction. HIES T cells showed impaired production of Th17 cytokines but normal production of classical proinflammatory cytokines including interleukin 1β. Normal human keratinocytes and bronchial epithelial cells were deeply dependent on the synergistic action of Th17 cytokines and classical proinflammatory cytokines for their production of antistaphylococcal factors, including neutrophil-recruiting chemokines and antimicrobial peptides. In contrast, other cell types were efficiently stimulated with the classical proinflammatory cytokines alone to produce such factors. Accordingly, keratinocytes and bronchial epithelial cells, unlike other cell types, failed to produce antistaphylococcal factors in response to HIES T cell–derived cytokines. These results appear to explain, at least in part, why HIES patients suffer from recurrent staphylococcal infections confined to the skin and lung in contrast to more systemic infections in neutrophil-deficient patients.


Abbreviations used: BD, β-defensin; CAA, Candida albicans antigen; CGD, chronic granulomatous disease; HIES, hyper-IgE syndrome; HMVEC-L, human lung microvascular endothelial cell; HUVEC, human umbilical vein endothelial cell; SEB, staphylococcal enterotoxin B; TLR, Toll-like receptor.

© 2009 Minegishi et al.
This article is distributed under the terms of an Attribution–Noncommercial–Share Alike–No Mirror Sites license for the first six months after the publication date (see http://www.jem.org/misc/terms.shtml). After six months it is available under a Creative Commons License (Attribution–Noncommercial–Share Alike 3.0 Unported license, as described at http://creativecommons.org/licenses/by-nc-sa/3.0/).


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Facebook Facebook   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:



  Home | Help | Feedback | Subscriptions | Archive | Search
TABLE OF CONTENTS